Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug Therapy
Year: 2020
Type: review
Abstract: Model-informed precision dosing (MIPD) has become synonymous with modern approaches for individualizing drug therapy, in which the characteristics of each patient are considered as opposed to applying a one-size-fits-all alternative. This review provides a brief account of the current knowledge, practices, and opinions on MIPD while defining an achievable vision for MIPD in clinical care based on available evidence. We begin with a historical perspective on variability in dose requirements and then discuss technical aspects of MIPD, including the need for clinical decision support tools, practical validation, and implementation of MIPD in health care. We also discuss novel ways to characterize patient variability beyond the common perceptions of genetic control. Finally, we address current debates on MIPD from the perspectives of the new drug development, health economics, and drug regulations.
Institutions: KTH Royal Institute of Technology, Royal Adelaide Hospital, Certara (United States), Monash University, University of Oxford, University of Manchester, University of Otago, University of Geneva, Inera (Sweden), University Hospital of Geneva, Swedish Association of Local Authorities and Regions, Pfizer (United States), University of Florida, The University of Sydney
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W3092492681
